These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Paediatric-onset lymphomatoid papulosis: results of a multicentre retrospective cohort study on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG). Blanchard M; Morren MA; Busschots AM; Hauben E; Alberti-Violetti S; Berti E; Avallone G; Tavoletti G; Panzone M; Quaglino P; Colonna C; Melchers RC; Vermeer MH; Gniadecki R; Mitteldorf C; Gosmann J; Stadler R; Jonak C; Oren-Shabtai M; Hodak E; Friedland R; Gordon E; Geskin LJ; Scarisbrick JJ; Mayo Martínez F; Noguera Morel L; Pehr K; Amarov B; Faouzi M; Nicolay JP; Kempf W; Blanchard G; Guenova E Br J Dermatol; 2024 Jul; 191(2):233-242. PubMed ID: 38595050 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of Associated Lymphomas and Their Risk Factors in Patients with Lymphomatoid Papulosis: A Retrospective Single-Center Study from Turkey. Baykal C; Kılıç Sayar S; Yazganoğlu KD; Büyükbabani N Turk J Haematol; 2021 Feb; 38(1):49-56. PubMed ID: 33389922 [TBL] [Abstract][Full Text] [Related]
10. Detection of clonal rearrangement of T-cell receptor genes in the diagnosis of primary cutaneous CD30 lymphoproliferative disorders. Greisser J; Palmedo G; Sander C; Kutzner H; Kazakov DV; Roos M; Burg G; Kempf W J Cutan Pathol; 2006 Nov; 33(11):711-5. PubMed ID: 17083688 [TBL] [Abstract][Full Text] [Related]
11. Lymphomatoid papulosis subtype C: A case report and literature review. Wang L; Chen F; Zhao S; Wang X; Fang J; Zhu X Dermatol Ther; 2021 Jan; 34(1):e14452. PubMed ID: 33099866 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathological Factors Associated with the Prognosis and Chronicity of Lymphomatoid Papulosis: A Retrospective Cohort Study. Jung JM; Lee MY; Won CH; Chang SE; Park CS; Lee MW; Lee WJ Clin Lymphoma Myeloma Leuk; 2022 Jul; 22(7):e541-e548. PubMed ID: 35307318 [TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous CD30+ lymphoproliferative disorder--a 10-year follow-up. A case report and differential diagnosis. Szpor J; Dyduch G; Gałazka K; Bahyrycz J; Stój A; Tomaszewska R Pol J Pathol; 2009; 60(1):43-8. PubMed ID: 19670703 [TBL] [Abstract][Full Text] [Related]
14. In search of prognostic indicators for lymphomatoid papulosis: a retrospective study of 123 patients. de Souza A; el-Azhary RA; Camilleri MJ; Wada DA; Appert DL; Gibson LE J Am Acad Dermatol; 2012 Jun; 66(6):928-37. PubMed ID: 21982062 [TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous peripheral T-cell lymphoma, not otherwise specified, associated with lymphomatoid papulosis after a 9-year follow up: A case report. Muraoka K; Fujimoto M; Iwahashi Y; Matsuzaki I; Yonei N; Murata SI; Jinnin M J Dermatol; 2020 Jun; 47(6):641-645. PubMed ID: 32323371 [TBL] [Abstract][Full Text] [Related]
16. Lymphomatoid papulosis: is a second lymphoma commoner among East Asians? Gan EY; Tang MB; Tan SH Clin Exp Dermatol; 2012 Mar; 37(2):118-21. PubMed ID: 21790721 [TBL] [Abstract][Full Text] [Related]
18. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Bekkenk MW; Geelen FA; van Voorst Vader PC; Heule F; Geerts ML; van Vloten WA; Meijer CJ; Willemze R Blood; 2000 Jun; 95(12):3653-61. PubMed ID: 10845893 [TBL] [Abstract][Full Text] [Related]